Related Experiment Videos
Myositis ossificans progressiva with parathyroid hyperplasia and polycystic ovary
Insights
Myositis ossificans progressiva is a rare genetic disorder characterized by bone formation in muscles. Autopsy revealed parathyroid hyperplasia and hormonal imbalances, suggesting a link to progressive ossification.
Area of Science:
- Medical Genetics
- Endocrinology
- Pathology
Background:
- Myositis ossificans progressiva (MOP) is a rare genetic disorder causing progressive ossification of soft tissues.
- Early symptoms can include congenital torticollis, indicating potential developmental abnormalities.
Observation:
- Autopsy of an 8-year, 11-month-old female with MOP revealed parathyroid hyperplasia.
- Elevated serum parathyroid hormone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were noted.
Findings:
- The findings suggest a potential link between parathyroid hyperactivity and the relentless ossification seen in MOP.
- Increased peripheral calcium consumption due to ossification may chronically stimulate parathyroid glands.
Implications:
- Understanding the endocrine involvement in MOP can guide future research into treatment strategies.
- This case highlights the complex interplay between genetic predisposition and hormonal regulation in MOP pathogenesis.
Abstract:
A report was made on an autopsy case of myositis ossificans progressiva in a girl who died at the age of 8 year and 11 months. The first symptom appeared as right wryneck ten days after birth. Parathyroid hyperplasia and polycystic ovary with high level of serum parathyroid hormone, FSH and LH were confirmed at autopsy. Parathyroid hyperactivity might be a secondary response to the continuous stimulation by increased peripheral consumption of calcium ions due to relentlessly progressive ossification in fibrous connective tissue.